QuantumCyte
PrivateLast Round
Seed
Aug 1, 2023
Total Funding Raised
$1.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
QuantumCyte operates in Healthcare & Life Sciences and is based in Sunnyvale, California. Its latest recorded funding round was a Seed round in August 2023.
QuantumCyte is a biotechnology company that develops an AI-integrated platform for automated tissue microdissection and molecular sample preparation to improve diagnostic accuracy in oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Precision Medicine, Medical AI, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantumCyte Comparables
Compare QuantumCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Targeted Bioscience | 85% | |
| NeuroInDx, Inc. | 78% | |
| Molecular Machines & Industries | 77% |
For institutional investors. Book with your work email.
QuantumCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2023 | ||||
| Grant | Nov 10, 2021 | ||||
| Accelerator | May 31, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
QuantumCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| Bayes Ventures | Seed |
| IndieBio | Seed, Accelerator |
| Green Generation Fund | Seed |
| Tet Ventures | Seed |
| Endless Frontier Labs | Seed |
| North South Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 40% QoQ, from 10 to 14 employees.
- Aug 20, 2026
Monthly visitors grew 101% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
QuantumCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QuantumCyte's valuation, stock price, and market status.
Is QuantumCyte a public or private company?
QuantumCyte is a private company.
What is the current stock price of QuantumCyte?
QuantumCyte is a private company, so its shares have no public market price. Caplight tracks QuantumCyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QuantumCyte worth (valuation)?
Valuation information for QuantumCyte is not publicly available.
Can I buy QuantumCyte stock?
QuantumCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QuantumCyte's last funding round?
QuantumCyte's most recent funding round was Seed on August 1, 2023.
Who are the main investors in QuantumCyte?
Key investors in QuantumCyte include IndieBio.
Will QuantumCyte IPO soon?
No public IPO plans have been announced for QuantumCyte.
How can I track QuantumCyte secondary market activity?
Caplight tracks bids, offers, and trades in QuantumCyte's shares on secondary markets.